Mariner, LLC Aclaris Therapeutics, Inc. Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 37,774 shares of ACRS stock, worth $69,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,774
Previous 48,101
21.47%
Holding current value
$69,126
Previous $54,000
72.22%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$26.1 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$17.6 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$16.3 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$11.4 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$8.54 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $122M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...